SEC Form 4 · accession 0001179110-15-007697
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John E Bishop
Officer — Senior VP, Pharmaceutical Scie
Period of report
May 11, 2015
Accepted (ET)
May 13, 2015 · 2:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 11, 2015 | M | 7,500 | $16.94 | A | 118,985 | D | |
| Common Stock | May 11, 2015 | S | 7,500 | $20.70 | D | 111,485 | D | |
| Common Stock | May 11, 2015 | M | 26,125 | $15.37 | A | 137,610 | D | |
| Common Stock | May 11, 2015 | S | 26,125 | $20.70 | D | 111,485 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $16.94 | May 11, 2015 | M | 7,500 | A | Dec 15, 2010 | Dec 15, 2016 | Common Stock | 7,500 | 0 | D |
| Stock Option (Right to Buy) | $15.37 | May 11, 2015 | M | 26,125 | A | Feb 18, 2014 | Feb 18, 2020 | Common Stock | 26,125 | 0 | D |
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2013.